Michael Husband

Michael Husband received his Bachelor of Engineering in Biomedical and Chemical Engineering from Vanderbilt University and his Masters of Science in Biomedical Engineering from Johns Hopkins University.

Michael started his career in the industry in medical device research and development for novel ways to measure respiratory and anesthetic gasses. He collaborated on several patents involving calculations of metabolic rate and cardiac output via respiratory gas flow measurement. He also gained clinical trial experience as a clinical engineer managing clinical trials for prostate and breast cancer tumor ablation treatment.

He began his government service with the Food and Drug Administration (FDA) as a senior medical device reviewer and Branch Chief for anesthesiology and respiratory devices specializing in the review of respiratory drug delivery systems, closed-loop ventilation, and anesthesia systems, and decision assist software for multi-parameter vital signs monitors. He then moved to the Biomedical Research and Development Authority (BARDA) where he worked as a Project Officer leading advanced development efforts for ventilators, respiratory personal protection equipment, influenza diagnostics, and vaccine delivery devices in support of pandemic preparedness.

Michael transitioned to the US Army Medical Research and Materiel Command (USMRMC) and continued to lead advanced development efforts for medical products in the area of combat casualty care with a focus on traumatic brain injury and psychological health diagnostics and treatments. He then took over as the Director of the Office of Regulated Activities where he set up an independent office to develop regulatory strategy and support for all medical products developed and funded by the Army and the Defense Health Agency (DHA). He was a key leader in working with the FDA on navigating Public Law 115-92 and the July 2018 Emergency Use Authorization for freeze-dried plasma.

Go to Linkedin                                                                                                                                                                                 Back to who we are